GenoGenix LLC recalls NAD+ (Nicotinamide adenine dinucleotide)
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility
- Products
-
- NAD+ (Nicotinamide adenine dinucleotide)
- Company
- GenoGenix LLC
- Where it was sold
-
US Nationwide.
Nationwide
- About this recall
- NAD+ (Nicotinamide adenine dinucleotide), a) 50 mg/mL, b) 100 mg/mL, 10 mL multi-dose vials, all strengths and presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health